Clinical characteristics and outcomes of COVID-19-associated encephalopathy in children
Li Li1, Hongmei Liao2,3, Xiaojun Kuang4
1Department of Radiology, Hunan Children's Hospital, No. 86 Ziyuan Road, 410007, Changsha, Hunan, China.
Insights
Coronavirus disease 2019 (COVID-19) can trigger brain disorders like encephalopathy and encephalitis in children. Autoimmune encephalitis is common, but acute necrotizing encephalopathy can lead to poor outcomes, though most children recover well.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is known to cause respiratory symptoms.
- Emerging evidence suggests COVID-19 also impacts the central nervous system, leading to encephalopathy and encephalitis.
- Limited data exists on pediatric COVID-19-associated encephalopathy, especially concerning specific subtypes.
Purpose of the Study:
- To assess the clinical features, neuroimaging and electroencephalography findings, treatment, and outcomes of pediatric COVID-19-associated encephalopathy/encephalitis.
- To identify specific subtypes of encephalopathy/encephalitis in children with COVID-19.
- To understand the neurological impact of COVID-19 on children.
Main Methods:
- Retrospective analysis of a single cohort of 13 hospitalized children with confirmed COVID-19 and associated encephalopathy/encephalitis.
- Descriptive analysis of clinical characteristics, magnetic resonance imaging (MRI) and electroencephalography (EEG) findings, treatment progression, and patient outcomes.
- Categorization of encephalopathy/encephalitis subtypes including autoimmune encephalitis, acute necrotizing encephalopathy, epilepsy, and vasculitis.
Main Results:
- Thirteen children (5% of 275 COVID-19 cases) developed encephalopathy/encephalitis (median age 35 months).
- Subtypes included autoimmune encephalitis (6 patients), acute necrotizing encephalopathy (3), epilepsy (3), and vasculitis (1).
- Seizures occurred in 62% of patients; 46% had elevated inflammatory markers. MRI and EEG findings varied by subtype. Acute necrotizing encephalopathy was associated with poor prognosis despite treatment, while 77% of children showed good recovery.
Conclusions:
- COVID-19 is identified as a significant trigger for encephalopathy/encephalitis in pediatric populations.
- Autoimmune encephalitis is a frequent subtype, whereas acute necrotizing encephalopathy presents a risk for poor outcomes.
- The study provides crucial insights into the neurological manifestations of COVID-19 in children, emphasizing the need for further research and tailored management strategies.
Abstract:
Apart from the typical respiratory symptoms, coronavirus disease 2019 (COVID-19) also affects the central nervous system, leading to central disorders such as encephalopathy and encephalitis. However, knowledge of pediatric COVID-19-associated encephalopathy is limited, particularly regarding specific subtypes of encephalopathy. This study aimed to assess the features of COVID-19-associated encephalopathy/encephalitis in children. We retrospectively analyzed a single cohort of 13 hospitalized children with COVID-19-associated encephalopathy. The primary outcome was the descriptive analysis of the clinical characteristics, magnetic resonance imaging and electroencephalography findings, treatment progression, and outcomes. Thirteen children among a total of 275 (5%) children with confirmed COVID-19 developed associated encephalopathy/encephalitis (median age, 35 months; range, 3-138 months). Autoimmune encephalitis was present in six patients, acute necrotizing encephalopathy in three, epilepsy in three, and central nervous system small-vessel vasculitis in one patient. Eight (62%) children presented with seizures. Six (46%) children exhibited elevated blood inflammatory indicators, cerebrospinal fluid inflammatory indicators, or both. Two (15%) critically ill children presented with multi-organ damage. The magnetic resonance imaging findings varied according to the type of encephalopathy/encephalitis. Electroencephalography revealed a slow background rhythm in all 13 children, often accompanied by epileptic discharges. Three (23%) children with acute necrotizing encephalopathy had poor prognoses despite immunotherapy and other treatments. Ten (77%) children demonstrated good functional recovery without relapse. This study highlights COVID-19 as a new trigger of encephalopathy/encephalitis in children. Autoimmune encephalitis is common, while acute necrotizing encephalopathy can induce poor outcomes. These findings provide valuable insights into the impact of COVID-19 on children's brains.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction
Hepatic Encephalopathy


